Methotrexate hepatotoxicity: what is the evidence?
Ahern
M J
MJ
Department of Medicine and Immunology, Flinders University of South Australia, Bedford Park. sahermj@rgh.sa.gov.au
Smith
M D
MD
Roberts-Thomson
P J
PJ
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008103:Liver Cirrhosis / Q000139:chemically induced; D008111:Liver Function Tests; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy; D018570:Risk Assessment
D018501:Antirheumatic Agents; D003879:Dermatologic Agents; D008727:Methotrexate